THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME

Similar documents
NEUROPSYCHOMETRIC TESTS

Exploration of a weighed cognitive composite score for measuring decline in amnestic MCI

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?

Anxiety, Depression, and Dementia/Alzheimer Disease: What are the Links?

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH

ORIGINAL ARTICLE Neuroscience INTRODUCTION MATERIALS AND METHODS

ORIGINAL CONTRIBUTION. Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in Mild Cognitive Impairment

Assessment of People with Early Dementia and their Families

Mild cognitive impairment A view on grey areas of a grey area diagnosis

Screening for Normal Cognition, Mild Cognitive Impairment, and Dementia with the Korean Dementia Screening Questionnaire

HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE?

Trail making test A 2,3. Memory Logical memory Story A delayed recall 4,5. Rey auditory verbal learning test (RAVLT) 2,6

Selection and Combination of Markers for Prediction

Cognitive Assessment 4/29/2015. Learning Objectives To be able to:

The ABCs of Dementia Diagnosis

Everyday Problem Solving and Instrumental Activities of Daily Living: Support for Domain Specificity

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease

February 8, Prepared By: Glen M. Doniger, PhD Director of Scientific Development NeuroTrax Corporation

Developing More Effective Paradigms for Assessing and Monitoring Cognitive Change Across the MCI and PreMCI Spectrum

Clinical Study Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer s and Cognitively Normal Elderly

Neuropsychological Evaluation of

Piano playing skills in a patient with frontotemporal dementia: A longitudinal case study

Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators

Diagnostic Disclosure of Mild Cognitive Impairment: what is told to the patient?

Alzheimer s disease dementia: a neuropsychological approach

Cognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.

David A Scott Lis Evered. Department of Anaesthesia and Acute Pain Medicine St Vincent s Hospital, Melbourne University of Melbourne

Papers. Detection of Alzheimer s disease and dementia in the preclinical phase: population based cohort study. Abstract.

Erin Cullnan Research Assistant, University of Illinois at Chicago

Improving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan

Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Award Number: W81XWH TITLE: "Longitudinal Study of a Novel Performance-based Measure of Daily Function."

ORIGINAL CONTRIBUTION. Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes Scores

Measure #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Assessment Toolkits for Lewy Body Dementia

Information Gathering Obtaining history is the most critical first step Patient-provided history may not be reliable Need info from relatives, friends

International Forum on HIV and Rehabilitation Research

Alzheimer's Disease Brain Failure, Stopping the Momentum. Katherine E. Galluzzi, DO, CMD, FACOFP dist.

I n the past three decades various cognitive screening

Regulatory Challenges across Dementia Subtypes European View

Learning objectives 6/20/2018

ORIGINAL CONTRIBUTION. Five-Year Follow-up of Cognitive Impairment

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

A comparison of diagnosis of dementia using GMS AGECAT algorithm and DSM-III-R criteria

Mild cognitive impairment (MCI) is an intermediate

Dementia is not normal aging!

Minimizing Misdiagnosis: Psychometric Criteria for Possible or Probable Memory Impairment

CHAPTER 2 CRITERION VALIDITY OF AN ATTENTION- DEFICIT/HYPERACTIVITY DISORDER (ADHD) SCREENING LIST FOR SCREENING ADHD IN OLDER ADULTS AGED YEARS

DATA CORE MEETING. Observational studies in dementia and the MELODEM initiative. V. Shane Pankratz, Ph.D.

MEASURING EVERYDAY COGNITIVE FUNCTIONING

AMNESTIC MINIMAL COGNITIVE IMPAIRMENT: BEYOND MEMORY

Mild Cognitive Impairment (MCI)

SOCIABLE DELIVERABLE D7.2a Interim Assessment of the SOCIABLE Platform and Services

I IADL. See Instrumental activities of daily living (IADL) Idiopathic rapid eye movement sleep behavior disorder (Idiopathic RBD), 136

COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E

AD Prevention Trials: An Industry Perspective

Dr. W. Dalziel Professor, Geriatric Medicine Ottawa Hospital. November /20/ Safety: Falls/Cooking/Unsafe Behaviour. 2.

The role of memory on patients with mild cognitive impairment. Sophia Vardaki, PhD National Technical University of Athens

DFCI IRB RECOMMENDED CONSENT LANGUAGE RELATING TO RETURN OF RESEARCH RESULTS

Understanding Dementia

The Rest is Noise. The Promise of ecoa in Increasing Signal Detection

Objectives. WAI Memory Diagnostic Clinic Network. Why is this important? Dementia Rates in Non-DS ID Strydom et al. 2007

Ann Acad Med Singapore 2013;42:315-9 Key words: Cognitive impairment, Dementia, SPMSQ, Validation

Health Literacy, Cognition & Asthma Self-Management. Rachel O Conor, MPH October 29, 2013

Recent publications using the NACC Database. Lilah Besser

WHOS complex needs clients data survey: assessment and treatment options

Measurement and Classification of Neurocognitive Disability in HIV/AIDS Robert K. Heaton Ph.D University of California San Diego Ancient History

sammanchester Assessing Cognition in Emergency and Acute Medicine September 2015

SUPPLEMENTAL MATERIAL

Detecting neurocognitive impairment in HIV-infected youth: Are we focusing on the wrong factors?

I n recent years, the concept of mild cognitive impairment

Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University

Baseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston

Recognizing Signs and Symptoms of Alzheimer's Disease in Earlier Stages Can Lead to Diagnosis

Mild Cognitive Impairment in the General Population: Occurrence and progression to Alzheimer s disease

Known as both a thief and murderer,

Intra-Individual Reaction Time Variability in Mild Cognitive Impairment and Alzheimer s Disease: Gender, Processing Load and Speed Factors

An Examination of Executive Function, Mild Cognitive Impairment and Fall Risk in Community Dwelling Older Adults

Supplementary Online Content

Trial Description. PLEASE NOTE: This trial has been registered retrospectively. Title

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

(5) Severe Alzheimer s Disease (SEV):

The Erlangen test of activities of daily living in persons with mild dementia or mild cognitive impairment (ETAM) an extended validation

LOTCA Assessment review. Georgina Wrack. University of the Sunshine Coast

8 th International Research Conference on Adolescents and Adults with FASD. April 18-21, 2018

DESCRIPTION: Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months

The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL)

Critical Review: Exploring the Use of Discourse Analysis in the Early Identification of Alzheimer s disease

Adding the AD8 Dementia Screen to the Panel Study of Income Dynamics

Driving and Dementia Practical Tips for the Family Physician. L. Lee, MD, MClSc, CCFP, FCFP 2014

Neuropsychological Correlates of Performance Based Functional Status in Elder Adult Protective Services Referrals for Capacity Assessments

Identification of Cognitive Impairment in HIV patients. Belinda Vicioso MD FACP, AGSF Jose Garcia Professor of Medicine UTSW

Measuring health-related quality of life in persons with dementia DOMS results & recommendations

Issues to Consider in the Clinical Evaluation and Development of Drugs for Alzheimer s Disease. The University of Tokyo Hospital

Preliminary Evidence: Diagnosed Alzheimer s Disease But Not MCI Affects Working Memory Capacity: 0.7 of 2.7 Memory Slots is Lost

Case Presentation. Cognition: changes with Normal Aging? Synonyms

Transcription:

PERNECZKY 15/06/06 14:35 Page 1 THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME R. PERNECZKY, A. KURZ Department of Psychiatry and Psychotherapy, Technical University of Munich, Germany. Correspondence Address: Dr. med. Robert Perneczky, Klinik und Poliklinik für Psychiatrie, Technische Universität München, Ismaningerstr. 22, 81675 München, Germany, Tel: +49(89)4140-4279, Fax: +49(89)4140-4923, Email: robert.perneczky@lrz.tum.de Abstract: Mild cognitive impairment (MCI) is a state between age-associated cognitive decline and dementia and therefore often a prodromal state of Alzheimer s disease. Current diagnostic criteria for MCI exclude the impairment of activities of daily living (ADL). However, there is evidence that complex ADL are already impaired in very early stages. Therefore, we explored if ADL are impaired already in the stage of MCI, which ADL are vulnerable to subtle cognitive changes in particular, and if ADL are correlated with demographic or clinical factors or severity of clinical symptoms. Furthermore, we examined the use of the assessment of complex ADL for the separation of MCI patients from healthy controls and the course of everyday activities over the time period of one year. Our results demonstrate that ADL requiring memory or complex reasoning are impaired in particular in MCI patients compared to healthy, age-matched controls and that the impairment is not related to demographical variables and the number of cognitive domains affected or severity. Furthermore, our findings show that the assessment of complex ADL may complement cognitive tests for the differentiation of MCI patients from controls and that MCI patients experience a significant deterioration in their everyday function over the time course of one year. We conclude that the progression from MCI to dementia is continuous and that currant diagnostic criteria are oversimplified although useful for pragmatic reasons. Key words: ADL, Alzheimer s disease, dementia, mild cognitive impairment. 1

PERNECZKY 15/06/06 14:35 Page 2 THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME Clinical and neuropathological studies suggest that Mild Cognitive Impairment (MCI) is a state between age-associated cognitive decline and mild dementia. At autopsy, the majority of patients with MCI show typical features of Alzheimer s disease (AD). Therefore, MCI frequently represents a prodromal stage of AD. MCI covers a cognitive spectrum which falls between physiological age-associated cognitive decline and dementia. According to current diagnostic criteria, MCI can be distinguished from normal cognitive ageing by a significantly lower performance on tests of memory or other cognitive functions. Moreover, MCI differs from mild dementia by intact global intellectual abilities and preserved activities of daily living (ADL). However, the population of patients diagnosed according to these criteria is highly heterogeneous in terms of aetiology, clinical symptoms, and prognosis. On average, patients with MCI progress to dementia at an annual rate of 12-15 per cent, but rates of more than 40 per cent have also been reported, as well as subgroups of patients who do not continue to go on to dementia or even revert to normal. The transition from MCI to dementia is probably continuous in terms of neuropathology and clinical symptoms. Autopsy studies have found a wide variation in the severity of AD-typical features, suggesting that patients gradually accumulate neuropathological changes as they progress from MCI to dementia. Moreover, more than one cognitive domain may be affected in MCI, and patients accumulate cognitive deficits in the course of the disease which gradually leads to a general intellectual deficit typical for AD. There is also evidence that complex ADL may already be impaired in the stage of MCI, whereas, by definition, loss of basic ADL indicates that the clinical stage of dementia has been reached. Complex ADL such as taking care of medication, handling finances, and keeping appointments seem especially vulnerable to subtle cognitive changes. However, little is known about the impairment of ADL in the stage of MCI. Our studies in this field of research were conducted as part of a national collaboration on dementia (Kompetenznetz Demenzen [1]) and were in part funded by the Federal Ministry of Research and Education (grant No 01GI0420). The sponsor played no role in the design, analysis, and interpretation of the present studies. MCI was diagnosed according to the diagnostic criteria developed for this particular network. Those criteria differ from the most frequently used criteria [2] in two respects. The definition of MCI used does not require subjective memory complaints since they are a rather poor predictor of memory impairment. Furthermore, our criteria specify the degree of ADL impairment that is consistent with the diagnosis of MCI. Deterioration of complex ADL is compatible with this diagnosis, whereas loss of basic activities is clearly excluded. Diagnostic procedures were based on the Consortium to Establish a Registry for 2

PERNECZKY 15/06/06 14:35 Page 3 Alzheimer s Disease Neuropsychological Assessment Battery. It was complemented by tests of episodic memory (Wechsler Memory Scale Logical Memory), information processing speed (Trail Making Test A), language, constructional ability (Clock Drawing Test), and executive function (Trail Making Test B). Interviews were conducted with the patients proxies using the Informant Questionnaire on Cognitive Decline in the Elderly to verify deterioration of cognitive ability from a previously higher level The Bayer-ADL scale was used for the assessment of basic ADL. Severity of cognitive decline was rated on the Clinical Dementia Rating scale. The impairment of complex ADL was rated on the Alzheimer s Disease Cooperative Study scale for ADL in MCI (ADCS-MCI- ADL) by an independent rater within four weeks after the first study visit. The Alzheimer s Disease Assessment Scale, cognitive subscale (ADAS-cog) was administered to obtain additional information on the patients cognitive abilities. Physical examination, laboratory screening, and structural brain imaging were also part of the diagnostic work-up. Our first study [3] included 48 MCI patients of the mentioned network and 42 cognitively healthy controls without memory complaints who were unrelated to the patients (spouses) and were also recruited from our unit. The objectives were to examine whether patients with MCI are impaired on ADL, which ADL are involved in particular, and whether limitations on ADL are associated with demographic variables, severity of symptoms or the number of cognitive domains affected. We showed that the overall score of the ADCS-MCI-ADL scale was significantly lower in the group of MCI patients than in the control group (mean value 40.95, standard deviation 9.81 vs. mean value 55.43, standard deviation 2.13, p < 0.001). Furthermore, patients performed significantly worse after statistical correction for multiple comparisons on 14 out of the 18 ADL covered by the interview. They were particularly impaired in activities requiring memory or complex reasoning such as checking the bank account, writing letters, or talking about recent events whereas there was no significant difference in basic ADL, such as putting on clothes and using household appliances. Moreover, there was no significant association between the ADCS-MCI- ADL overall score and demographical variables or the number of cognitive domains affected. However, MMSE and ADCS-MCI-ADL scores were moderately, but significantly associated (Spearman s rho 0.37, p = 0.016). A second analysis [4] including 45 patients and 30 age-matched controls from the same network was designed to evaluate the accuracy of the ADCS- MCI-ADL for the discrimination between MCI patients and healthy controls in comparison to the ADAS-cog. Furthermore, we tried to prove that the contribution of the assessment of ADL to the separation of MCI subjects from cognitively healthy controls is equal to that of a cognitive test. The 3

PERNECZKY 15/06/06 14:35 Page 4 THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME results of receiver operator curve (ROC) analyses showed that both instruments discriminated well between patients and controls (ADCS-MCI- ADL: sensitivity 0.89, specificity 0.97 at a cut-off at 52 points; ADAS-cog: sensitivity 0.78, specificity 1.0 at a cut-off at 10 points) and that the test accuracy of the ADCS-MCI-ADL was slightly superior to the accuracy of the ADAS-cog (area under the curve 0.97 vs. 0.93). With regard to the logistic regression equation built by adding the two tests stepwise to a null model, both ADCS-MCI-ADL and ADAS-cog were strong predictors of caseness according to the expert diagnosis as the gold standard. In addition to the these findings, the preliminary results of a third longitudinal study including 24 MCI patients of our network showed that there was a significant decline on the ADCS-MCI-ADL overall score over the time period of one year (mean value 46.73, standard deviation 8.12 vs. mean value 39.55, standard deviation 12.36, p = 0.017; : mean value 7.18, standard deviation 3.56) suggesting that the longitudinal assessment of complex ADL may serve as a measure for the course of MCI. However, the high variability of the data illustrates the prognostic heterogeneity of MCI. Our findings demonstrate that MCI patients as a group perform significantly poorer than age-matched cognitively unimpaired controls on complex ADL. This finding is consistent with studies that report that patients with questionable dementia are more impaired on informantreported ADL than controls. Patients were in particular impaired on ADL demanding memory or complex reasoning and there was not a single patient without any impairment on ADL. Furthermore, we showed that the assessment of complex ADL may serve as a part of the diagnostic procedures in MCI and that it may complement cognitive tests since informant-reported ADL and cognitive tests contributed equally to the differentiation between MCI patients and cognitively healthy controls. Our preliminary finding that there is a significant worsening of ADL within one year indicates that the assessment of complex ADL might be useful for prognostic conclusions and denote a patient s position on the scale between MCI and dementia. In conclusion, our findings suggest that current diagnostic criteria for MCI which exclude the impairment of ADL may be oversimplified, although useful in a pragmatic point of view. Moreover, our results underline that there is no sharp borderline between MCI and mild dementia. The two syndromes mostly represent two overlapping stages of the same underlying disease and the progression is continuous. Therefore, it may be difficult or sometimes even impossible to decide whether progression from MCI to dementia has already occurred in an individual patient. The finding that the impairment of ADL is independent from the number of cognitive domains affected highlights that the deterioration on 4

PERNECZKY 15/06/06 14:35 Page 5 one cognitive domain may be sufficient to interfere with everyday life. Further extensive research is needed to explore the role of ADL in the MCI syndrome in more detail. REFERENCES 1. Perneczky R, Wolf S, Reischies F, Kühl KP, Kurz A. A Comprehensive Inventory for the Diagnosis and Follow-Up of Dementia. Nervenheilkunde 2005; 24: 471-475 2. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308 3. Perneczky R, Pohl C, Sorg C, Hartmann J, Tosic N, Grimmer T, Heitele S, Kurz A. Impairment of Activities of Daily Living Requiring Memory or Complex Reasoning as Part of the MCI syndrome, in press, DOI 10.1002/gps.1444 4. Perneczky R, Wagenpfeil S, Pohl C, Sorg C, Hartmann J, Kurz A. Assessment of Complex Activities of Daily Living is Essential for the Diagnosis of the MCI Syndrome (submitted: Age Ageing) 5